These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 7070726)

  • 1. Effect of cytologic screening on the detection of cervical carcinoma.
    Yajima A; Mori T; Sato S; Wakisaka T; Suzuki M
    Obstet Gynecol; 1982 May; 59(5):565-8. PubMed ID: 7070726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of cytologic mass screening in the Federal Republic of Germany.
    Soost HJ; Bockmühl B; Zock H
    Acta Cytol; 1982; 26(4):445-52. PubMed ID: 6957096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenocarcinoma in situ of the cervix: sensitivity of detection by cervical smear: will cytologic screening for adenocarcinoma in situ reduce incidence rates for adenocarcinoma.
    Smith HO; Padilla LA
    Cancer; 2002 Dec; 96(6):319-22. PubMed ID: 12478677
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cervical cancer in Frederiksborg County 1990-1991].
    Ingeholm P; Glenthøj A
    Ugeskr Laeger; 1996 Feb; 158(7):915-8. PubMed ID: 8638329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening.
    Mitchell H; Hocking J; Saville M
    Cancer; 2003 Dec; 99(6):336-41. PubMed ID: 14681940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on the prevalence and incidence rate of epithelial neoplasia of the uterine cervix by mass survey using mobile units].
    Hando T; Sugimori H; Higashiiwai H; Kuroshima Y; Nishiya I; Sugimoto O; Noda K
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2287-90. PubMed ID: 4078419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Previous cytology in patients with carcinoma of the cervix].
    Hando T; Sugimori H; Higashiiwai H; Kuroshima Y; Nishiya I; Sugimoto O
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Oct; 38(10):1692-6. PubMed ID: 3782952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriate frequency of mass-screening for uterine cervical cancer.
    Iwanari O
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Oct; 39(10):1799-805. PubMed ID: 3429977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe cervical glandular cell lesions and severe cervical combined lesions: predictive value of the papanicolaou smear.
    van Aspert-van Erp AJ; Smedts FM; Vooijs GP
    Cancer; 2004 Aug; 102(4):210-7. PubMed ID: 15368312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [No major difference between population screening for cervical carcinoma at the present screening interval of 5 years and the former interval of 3 years].
    Vinkesteijn AS; Siemens FC; Boon ME; Kuypers JC; Kok LP
    Ned Tijdschr Geneeskd; 2004 Sep; 148(36):1781-5. PubMed ID: 15495942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of the Leiden mass screening for cervix uteri carcinoma; the 'young' (24-34 years) versus the 'old' (35-54 years) group of women].
    Boon ME; de Graaff Guilloud-Gentenaar JC; Beck S
    Ned Tijdschr Geneeskd; 1990 Aug; 134(32):1545-9. PubMed ID: 2392176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening.
    Kennedy AW; Salmieri SS; Wirth SL; Biscotti CV; Tuason LJ; Travarca MJ
    Gynecol Oncol; 1996 Oct; 63(1):14-8. PubMed ID: 8898161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial dysplasia of the cervix uteri. The population screening for cervical carcinoma in the County of Maribo, 1967-69.
    Berget A
    Dan Med Bull; 1974 Aug; 21(5):169-71. PubMed ID: 4851895
    [No Abstract]   [Full Text] [Related]  

  • 14. Limited education as a risk factor in cervical cancer.
    Corral F; Cueva P; Yépez J; Montes E
    Bull Pan Am Health Organ; 1996 Dec; 30(4):322-9. PubMed ID: 9041743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe cervical glandular cell lesions with coexisting squamous cell lesions.
    van Aspert-van Erp AJ; Smedts FM; Vooijs GP
    Cancer; 2004 Aug; 102(4):218-27. PubMed ID: 15368313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytologic features of squamous cell carcinoma in situ involving endocervical glands in endocervical cytobrush specimens.
    Selvaggi SM
    Acta Cytol; 1994; 38(5):687-92. PubMed ID: 8091898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a hospital based cytology screening program.
    Das DK; Murthy NS; Bhatnager P; Juneja A; Sharma S; Pant JN; Bhatt NC; Sharma KC; Luthra UK
    Neoplasma; 1992; 39(6):381-4. PubMed ID: 1491729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The limitation of screening effect. A review of cervical disorders in previously screened women.
    Gad C; Koch F
    Acta Cytol; 1977; 21(6):719-22. PubMed ID: 274877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of the screening history of Alberta women with invasive cervical cancer.
    Stuart GC; McGregor SE; Duggan MA; Nation JG
    CMAJ; 1997 Sep; 157(5):513-9. PubMed ID: 9294389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the histopathological pattern of carcinoma of the cervix in Ilorin, Nigeria.
    Adeniji KA
    Niger J Med; 2001; 10(4):165-8. PubMed ID: 11805997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.